Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,072,272
+$399,755 QoQ
Shares Held
12,209
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
#1,635
of 4,153 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Probity Advisors, Inc. holds $17,628,696 across 10 Drug Manufacturers - General names. ABBV ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,714 | $3,255,253 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
12,209 | $3,072,272 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,934 | $2,561,519 | |
| 4 | JNJ |
Johnson & Johnson
|
9,274 | $2,355,317 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,128 | $1,532,251 | |
| 6 | GSK |
GSK plc
|
24,377 | $1,277,842 | |
| 7 | PFE |
Pfizer Inc
|
50,988 | $1,227,791 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
20,006 | $1,152,745 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,072,272 | 12,209 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,672,517 | 12,288 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,858,866 | 12,512 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,028,311 | 13,079 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,482,853 | 13,376 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,813,015 | 13,426 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,396,462 | 13,486 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $2,743,984 | 13,895 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,432,668 | 14,183 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,682,697 | 14,732 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,366,856 | 15,273 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,325,186 | 15,599 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,085,889 | 15,482 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $2,504,631 | 15,498 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,152,325 | 16,037 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,729,004 | 17,818 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,980,392 | 18,385 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,752,005 | 20,325 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,232,801 | 20,699 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,416,916 | 21,457 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,351,295 | 21,727 | Shares | Sole | 2021-04-28 | |
| 2020-09-30 | $1,880,031 | 21,464 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,122,357 | 21,617 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,600,904 | 21,012 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||